Home
Training STI Expert Hour Webinar: Why the Dose Matters: PrEP Strategies for HIV
STI Expert Hour Webinar: Why the Dose Matters: PrEP Strategies for HIV
January 11, 2022
Presented by Katherine Yang, PharmD, MPH
Pre-Exposure prophylaxis (PrEP) has been shown to be safe and effective in reducing HIV infection. With recent updates in PrEP, many options are available, and selection of the best regimen is the key to success. The purpose of this webinar is to review the pharmacologic basis for drug dosing and outline gaps and challenges in management.
Learning objectives
Review the key pharmacokinetic and pharmacodynamic properties of emtricitabine/tenofovir disoproxil fumarate, emtricitabine/tenofovir alafenamide, and cabotegravir.
Identify patients who may be appropriate for Daily vs. Event-Driven PrEP.
Review key side effects of PrEP and potential strategies for management.
Describe the role of adherence on PrEP effectiveness.
2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Perinatal HIV and Congenital Syphilis—Dear Colleague Letter from CDPH
November 16, 2021: CDPH is asking for assistance in responding to concerning increases in congenital syphilis and perinatal HIV in California. Perinatal HIV transmission and congenital syphilis can be prevented with timely testing and treatment. A common risk factor, however, is receiving late or no prenatal care.
CDPH requests your assistance to implement the following policies and best practices to Screen, Treat and Prevent, and Prepare for perinatal transmissions
An understanding of social determinants is essential to the implementation of effective HIV treatment or prevention interventions. This engaging and informative one-hour online course, based on our popular two-day instructor-led training, provides an introduction to social determinants and HIV.
Coming Together for Sexual Health is a podcast for providers and advocates passionate about health equity and inclusive care. We unpack both the how and the why of improving sexual and reproductive health. From root structural problems to improvements in clinical care, we keep the attention on people most impacted by STIs, HIV, and emerging infectious diseases.
We are powered by leading sexual health trainers at UCSF’s California Prevention Training Center. Join our sex-positive conversations with expert clinicians, public health leaders, and community members wherever you get your podcasts.
A small leak during a big laugh might hint towards a bigger story. In this episode exploring the pelvic floor, Dr. Olga Ramm and patient Nicole Curutchet answer the age-old question-…
In this episode, Dr. Eleanor Bimla Schwartz and Dr. Kelly Treder discuss the misconceptions of tubal sterilization, for example, that is it 100% fool-proof, that the surgery is reversible, that…
Marnina Miller, co-executive director at the Positive Women’s Network (PWN), shares her experiences as a Black woman with HIV. She says, “I want liberation… I don’t want equity. I don’t…
Dr. Bethany Golden, a nurse midwife, shares the many ways midwives support sexual and reproductive health beyond childbirth. Bethany shares how midwives provide holistic, patient-centered care, including contraception, STI treatment,…
Monica Gandhi, MD, reflects on her decades-long work in HIV care, from providing care early in the epidemic to leading implementation of today’s groundbreaking medical advances.
Ina Park, MD, is back again for a focused look at her (second) favorite sexually transmitted infection: syphilis (favorite because it’s fascinating). She says, “it’s one of the most challenging…
Did you know the visible part of the clitoris is less than one-third of its actual size? In this second part of our series with Rachel Gross, Rachel and Tammy…
The CDC’s 2023 STI Report is in, and for the first time in years, there’s good news. Tune in to our latest episode with Dr. Ina Park, a nationally recognized…
Meet Rachel E. Gross, science journalist and author of Vagina Obscura: An Anatomical Voyage. In this first part of a two–part conversation, Rachel shares how her personal experience with bacterial vaginosis inspired…
S4 E9 From Red Ribbons to Leather Straps: Rodney McCoy’s Trailblazing Tale of HIV Prevention and Pleasure In this episode, Rodney McCoy, a Black queer man with over four decades…
Michelle Lopez, a bisexual Caribbean woman diagnosed with HIV, realized that women living with HIV continue to be ostracized for both wanting and having sex. Michelle knew she had to…
Home
Training STD/HIV Partner Services Interview Demonstration
STD/HIV Partner Services Interview Demonstration
This video provides an example of a mock partner services interview with a syphilis client. HIV prevention is also addressed extensively during the interview.
CDC Train’s Passport to Partner Services online modules are for providers who conduct all aspects of Partner Services (PS), and they are designed for PS professionals of all experience levels.
CDC Train’s Integrating PrEP into Partner Services course is designed to give Disease Intervention Specialists (DIS) the tools they need to offer HIV pre-exposure prophylaxis (PrEP) to their clients by reviewing what PrEP is, how it differs from post-exposure prophylaxis (PEP) and how to assess whether a patient is eligible.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.AcceptDisable
